Caricamento...
Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
Glaucoma is the second most common cause of blindness, affecting 70~80 million people around the world. The death of retinal ganglion cells (RGCs) is the main cause of blindness related to this disease. Current therapies do not provide enough protection and regeneration of RGCs. A novel opportunity...
Salvato in:
| Pubblicato in: | Int J Stem Cells |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Korean Society for Stem Cell Research
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741193/ https://ncbi.nlm.nih.gov/pubmed/28844129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15283/ijsc17029 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|